ipamorelin gfr Mod GRF 1-29 & Ipamorelin

Therapeutic and Performance Applications Addressing Growth Hormone Deficiency Growth hormone deficiency (GHD) can affect individuals across different age groups, leading to a range of symptoms

However, unlike other GH-Secretagogues this pentapeptide doesnt release the same volumes of cortisol, acetylcholine, prolactin and aldosterone For this reason, lpamorelin has been considered the first selective GH which promotes secretion

This decline contributes to various age-related changes including reduced muscle mass, increased body fat, decreased bone density, and diminished energy levels

Unlike other treatments, it addresses the neurological pathways involved in sexual arousal